Clinical pregnancy · women with anovulatory PCOS and CC resistance
LOD of one ovary (unilateral) may leads to lower clinical pregnancy compared with LOD of both ovaries (bilateral) (low certainty).
1 finding from 1 review
Quality of life (9 months) – EHP‐30 pain · endometriosis
1 finding from 1 review
Quality of life (9 months) – EHP‐30 control and powerlessness · endometriosis
1 finding from 1 review
Quality of life (emotional) · endometriosis
1 finding from 1 review
Quality of life (9 months) – EHP‐30 social support · endometriosis
1 finding from 1 review
Quality of life (9 months) – EHP‐30 self‐image · endometriosis
1 finding from 1 review
Adverse events · endometriosis
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).
1 finding from 1 review
All‐cause mortality · patients undergoing laparoscopy
1 finding from 1 review
All‐cause mortality · patients undergoing laparoscopy
The review found no eligible studies for this question.
1 finding from 1 review
Vascular injury (major vessels and abdominal wall vessels) · patients undergoing laparoscopy
It is very uncertain whether direct vision entry changes vascular injury (major vessels and abdominal wall vessels) compared with veress needle entry (very low certainty).
1 finding from 1 review
Visceral injury (bladder or bowel) · patients undergoing laparoscopy
It is very uncertain whether direct vision entry changes visceral injury (bladder or bowel) compared with veress needle entry (very low certainty).
1 finding from 1 review
Gas embolism · patients undergoing laparoscopy
The review found no eligible studies for this question.
1 finding from 1 review
Solid organ injury · patients undergoing laparoscopy
The review found no eligible studies for this question.
1 finding from 1 review